REGN   $1139.06  -0.67% Market Closed After Close 1146.75 0.68%

Regeneron Pharmaceuticals Inc
Total Cash 9.81B
totalCashPerShare 90.879
EBITDA 4.52B
Total Debt 2.70B
quickRatio 4.425
currentRatio 5.439
Total Revenue 13.49B
debtToEquity 9.585
Revenue/Share 125.831
ROA 0.07615
ROE 0.16551
grossProfits
freeCashflow 2.09B
operatingCashflow 4.07B
earningsGrowth 0.46
revenueGrowth 0.123
grossMargins 0.53271997
ebitdaMargins 0.33501998
operatingMargins 0.30828
profitMargins 0.32037997
enterpriseValue 117.38B
forwardPE 23.556986
floatShares 103.45M
sharesOutstanding 108.42M
sharesShort 2.10M
sharesShortPriorMonth 2.01M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.90%
Short Ratio help_outline 4.46%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 261.407
Price To Book help_outline 4.41
earningsQuarterlyGrowth 0.48
netIncomeToCommon 4.32B
trailingEps 37.71%
forwardEps 48.96%
enterpriseToEbitda 25.97
lastDividendValue
lastDividendDate
currentQuarterEstimate 11.83 3Q 2024
institutionsCount 1940
lastUpdated Sept. 16, 2024, 11:25 a.m.